W. Hong

发表

Increased epidermal growth factor receptor expression in metaplastic bronchial epithelium.

S. Lippman, J. Lee, R. Morice, 1996, Clinical cancer research : an official journal of the American Association for Cancer Research.

Timing of radiotherapy in small cell lung cancer.

J. Lee, W. Hong, J. Lee, 1994, International journal of radiation oncology, biology, physics.

The incidence of second primary tumors in long-term survivors of small-cell lung cancer.

S. Lippman, J. Lee, J. Lee, 1992, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II randomized study of biomarker-directed treatment for non-small cell lung cancer (NSCLC): The BATTLE (Biomarker-Integrated Approaches of Targeted Therapy for Lung Cancer Elimination) clinical trial program.

I. Wistuba, J. Lee, R. Herbst, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase I trial of oral green tea extract in adult patients with solid tumors.

F. Khuri, K. Pisters, D. Shin, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II study of topotecan in patients with advanced non-small-cell lung cancer previously untreated with chemotherapy.

R. A. Robinson, S. Lippman, J. Lee, 1996, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomized phase III study of chemoradiation with or without amifostine for patients with favorable performance status inoperable stage II-III non-small cell lung cancer: preliminary results.

F. Khuri, C. Stevens, R. Komaki, 2002, Seminars in radiation oncology.

Long-term impact of smoking on lung epithelial proliferation in current and former smokers.

F. Khuri, J. Lee, R. Morice, 2001, Journal of the National Cancer Institute.

Smoking affects treatment outcome in patients with advanced non-small cell lung cancer.

M. Spitz, J. Lee, A. Tsao, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Retinoic acid receptor-beta as a prognostic indicator in stage I non-small-cell lung cancer.

S. Lippman, F. Khuri, R. Lotan, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Prognostic factors in lung cancer.

J. Lee, W. Hong, 1992, The New England journal of medicine.

Management strategies for recurrent non-small cell lung cancer.

F. Fossella, J. Lee, W. Hong, 1997, Seminars in oncology.

Clinical and immunomodulatory effects of combination immunotherapy with low-dose interleukin 2 and tumor necrosis factor alpha in patients with advanced non-small cell lung cancer: a phase I trial.

J. Roth, L. Owen-Schaub, S. C. Yang, 1991, Cancer research.

Primary and Secondary Prevention of Lung Cancer: an International Association for the Study of Lung Cancer workshop.

J. Mulshine, B. Johnson, J. Battey, 1995, Lung cancer.

The value of interventional radiology in clinical trial teams: experience from the BATTLE lung cancer trials.

I. Wistuba, J. Lee, R. Herbst, 2020, Clinical radiology.

Elevated plasma von Willebrand factor levels and arterial occlusive complications associated with cisplatin-based chemotherapy.

J. Moake, D. Karp, C. Rudy, 1985, Oncology.

Summary of phase II data of docetaxel (Taxotere), an active agent in the first- and second-line treatment of advanced non-small cell lung cancer.

F. Fossella, J. Bérille, J. Lee, 1995, Seminars in oncology.

Tumor epidermal growth factor receptor studies in patients with non-small-cell lung cancer or head and neck cancer treated with monoclonal antibody RG 83852.

R. Perez-soler, N. Donato, D. Shin, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Primary chemotherapy of brain metastasis in small-cell lung cancer.

W. Murphy, B. Glisson, J. Lee, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.

I. Wistuba, J. Lee, J. Welsh, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Multi-institutional phase I/II trial of oral bexarotene in combination with cisplatin and vinorelbine in previously untreated patients with advanced non-small-cell lung cancer.

R. Figlin, F. Khuri, J. Rigas, 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Expression of blood-group antigen A--a favorable prognostic factor in non-small-cell lung cancer.

A. Sahin, B. Brown, W. Hittelman, 1991, The New England journal of medicine.

Interphase cytogenetics in paraffin sections of lung tumors by non-isotopic in situ hybridization. Mapping genotype/phenotype heterogeneity.

W. Hittelman, J. Ro, S. Y. Kim, 1993, The American journal of pathology.

Maximum-tolerated dose defined for single-agent gemcitabine: a phase I dose-escalation study in chemotherapy-naive patients with advanced non-small-cell lung cancer.

S. Lippman, R. Perez-soler, F. Fossella, 1997, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer.

F. Khuri, J. Roth, J. Lee, 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Comparison of p53 immunoreactivity in fresh-cut versus stored slides with and without microwave heating.

J. J. Lee, J. Ro, H. Shin, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Cisplatin, etoposide, and paclitaxel in the treatment of patients with extensive small-cell lung carcinoma.

D. Nyberg, R. Perez-soler, J. Kurie, 1999, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Implantation metastasis of carcinoma after percutaneous fine-needle aspiration biopsy.

D. Shin, I. Dimery, R. Dekmezian, 1992, Chest.

Phase II study of cisplatin, ifosfamide with mesna, and etoposide (PIE) chemotherapy for advanced non-small cell lung cancer.

J. Lee, W. Hong, J. Greenberg, 1992, Seminars in oncology.

A pilot trial of hyperfractionated thoracic radiation therapy with concurrent cisplatin and oral etoposide for locally advanced inoperable non-small-cell lung cancer: a 5-year follow-up report.

R. Komaki, J. Cox, F. Fossella, 1998, International journal of radiation oncology, biology, physics.

Expression of p53 oncoprotein in non-small-cell lung cancer: a favorable prognostic factor.

J. Lee, W. Hittelman, J. Ro, 1995, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Squamous metaplasia of the bronchial mucosa and its relationship to smoking.

S Lippman, S. Lippman, R. Morice, 1993, Chest.

Phase II trial of paclitaxel, ifosfamide, and cisplatin in patients with recurrent head and neck squamous cell carcinoma.

K. Ang, S. Lippman, F. Khuri, 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Phase II clinical trial of suberoylanilide hydroxamic acid (SAHA) in patients (pts) with recurrent and/or metastatic head and neck cancer(SCCHN).

A. Gillenwater, V. Papadimitrakopoulou, M. Kies, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Modulation of proliferating cell nuclear antigen in the bronchial epithelium of smokers.

S. Lippman, F. Khuri, J. Lee, 2001, Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology.

Combination immunotherapy for non-small cell lung cancer. Results with interleukin-2 and tumor necrosis factor-alpha.

J. Roth, L. Owen-Schaub, S. C. Yang, 1990, The Journal of thoracic and cardiovascular surgery.

Chemoprevention of lung cancer.

J. Lee, W. Hong, M. Huber, 1993, Seminars in oncology.

Autofluorescence bronchoscopy in the detection of squamous metaplasia and dysplasia in current and former smokers.

F. Khuri, W. Franklin, R. Morice, 1998, Journal of the National Cancer Institute.

Disturbing central nervous system complications following combination chemotherapy and prophylactic whole-brain irradiation in patients with small cell lung cancer.

R. J. Cersosimo, D. Karp, W. Hong, 1985, Cancer treatment reports.

Long-term follow-up of patients enrolled in a randomized trial comparing perioperative chemotherapy and surgery with surgery alone in resectable stage IIIA non-small-cell lung cancer.

J. Roth, R. Komaki, E. Atkinson, 1998, Lung cancer.

Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC).

S. Lippman, R. Lotan, I. Wistuba, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Abstract 2658: Phase II study of chemoradiation therapy and erlotinib for stage III non-small cell lung cancer

I. Wistuba, J. Lee, J. Welsh, 2011 .

A phase II trial of pemetrexed (P) plus carboplatin (C) in patients (pts) with advanced non-small-cell lung cancer (NSCLC).

C. Obasaju, R. Herbst, K. Pisters, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Study of multidrug resistance (mdr1) gene in non-small-cell lung cancer.

D. Shin, H. Shin, W. Hong, 1992, Anticancer research.

Phase II study of combination cisplatin, docetaxel and erlotinib in patients with metastatic/recurrent head and neck squamous cell carcinoma (HNSCC).

S. Lippman, A. Tsao, M. Truong, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Insulin-like growth factor-1 receptor/epidermal growth factor receptor (EGFR) heterodimerization and resistance to epidermal growth factor receptor tyrosine kinase inhibitors in non-small-cell lung cancer.

F. Morgillo, H. Lee, W. Hong, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.